Exosomes

Buy Exosomes Wholesale With Cold-Chain Shipping

Our current stock includes Exojuv exosomes, a plant-derived preparation for professional topical use. Exosome preparations are more sensitive to storage conditions than most aesthetic products a clinic stocks, which makes shipping handling a purchasing criterion rather than a logistics detail. We maintain temperature-controlled conditions from our facility through to delivery, so practices receive product that has not sat in ambient transit. Practitioners can buy exosomes online for initial stocking or recurring replenishment, at wholesale pricing for licensed aesthetic and healthcare professionals.

Exosome Products We Carry

Exojuv exosomes is a professional-use, plant-derived exosome preparation developed from Centella asiatica callus cultures. Each vial contains approximately 5 billion plant-derived exosomes as a lyophilized powder, reconstituted with a companion activator containing hyaluronic acid, amino acids, glutathione, niacinamide, vitamins, and polynucleotides. Once prepared, the solution is applied topically following aesthetic procedures. The plant origin is the detail most practitioners ask about first. Unlike human- or animal-derived extracellular vesicle products, Exojuv avoids the sourcing and ethical questions attached to donor-derived material while remaining suitable for cosmetic skin revitalization protocols.

Why Practitioners Choose Exosomes

Exojuv is cell-free and plant-based, built on Centella asiatica rather than human tissue. Human-derived exosome products are the specific target of FDA enforcement attention, so a plant-derived topical sits in a defensible position that a clinic can explain to a patient without hedging. For practices that want to work in regenerative-inspired skincare without introducing donor biological material, that distinction does most of the work. Exosomes also do not replace a service; they layer onto one. A practice already running microneedling, laser resurfacing, or RF microneedling can add a post-procedure application with minimal added chair time and no new equipment. That makes it an incremental revenue layer on appointments the clinic is already booking, which is a different proposition from launching a standalone treatment and having to build demand for it. Practices offering skin boosters or collagen-induction treatments generally slot exosomes into an existing skin-quality pathway rather than marketing them separately.

What Are Exosomes and How Do They Work?

Exosomes are extracellular vesicles measuring approximately 30 to 150 nanometers in diameter. A lipid bilayer membrane encloses cargo that includes proteins, lipids, messenger RNA, microRNA, and other signaling molecules, and the vesicle delivers that cargo to recipient cells. This is the mechanism behind their role in intercellular communication.[1] In regenerative aesthetics, topical exosome preparations are being investigated for effects on inflammatory signaling, fibroblast activity, and extracellular matrix remodeling. Reviews of the field point toward applications in wound repair and skin aging, while noting that yield, batch heterogeneity, and preservation remain unresolved.[2] The evidence remains early-stage and heterogeneous.[2] Standardized protocols, potency assays, and long-term outcome data are not established. Exosomes are a biologically plausible adjunct with encouraging early findings, not a proven replacement for established regenerative therapies, and practitioners should present them to patients on those terms.

Exosomes vs PRP

PRP is autologous. It requires venipuncture, centrifugation, and chair time, but because the material is the patient's own, the regulatory position is uncomplicated, and the evidence base is considerably older and larger. Exosomes are exogenous and purchased rather than produced in-clinic. There is no blood draw, no centrifuge, and no processing delay, which makes the protocol faster and simpler to staff. The trade-off is a regulatory position that remains unsettled and an evidence base that is younger. Neither modality supersedes the other, and practices that offer both are choosing on patient-level factors rather than settling a general question. Patients unwilling to undergo a blood draw are candidates for the topical protocol. Those who want the modality with the longer track record are better served by PRP. Clinics building out autologous regenerative treatments alongside exosomes can also stock PRP kits.

Clinical Integration and Protocols

Topical exosomes are applied immediately after procedures that transiently increase skin permeability. Microneedling, fractional laser resurfacing, and RF microneedling are the common pairings. The reconstituted solution is spread evenly across the treated area while the microchannels remain open. Exosomes are generally worked into a course rather than delivered as a single treatment, with scheduling driven by the underlying procedure and clinical assessment over time. Some practitioners include them in scalp protocols alongside microneedling, though evidence for exosome hair applications is preliminary and should be presented that way to patients. Combination planning is where most of the treatment-design work happens. Exosome skin rejuvenation protocols are frequently built alongside mesotherapy injections or skin boosters, with the sequencing set by what the patient's skin can tolerate in a single visit.

Storage and Cold-Chain Handling

Exojuv should be stored refrigerated at 2°C to 8°C, protected from light, and used promptly after reconstitution in line with the manufacturer's instructions. Cold-chain integrity is the reason exosome sourcing is not interchangeable between suppliers. Bioactivity here is temperature-dependent, so a product that has broken cold chain in transit may arrive intact in appearance and inert in practice, with no way for the receiving clinic to tell. Practitioners evaluating where to purchase exosomes online should ask what temperature control a supplier maintains between manufacture and delivery, and what happens to a shipment that experiences an excursion.

Exosome Safety Profile

Topical exosome preparations are generally well tolerated when applied by trained professionals according to manufacturer directions. Common transient effects include:

• Mild erythema
• Localized swelling
• Warmth or tenderness
• Temporary skin sensitivity

Less commonly, prolonged irritation or hypersensitivity to a formulation component may occur, which makes pre-treatment assessment worthwhile. Topical exosomes should not be applied to:

• Active skin infections or inflamed treatment areas
• Open wounds unrelated to the intended procedure
• Patients with known hypersensitivity to any formulation ingredient
• Recently compromised skin barriers beyond the manufacturer's recommended indications
• Patients who are pregnant or breastfeeding, as a precaution given limited data

As with any regenerative aesthetic protocol, practitioners should set realistic expectations, discuss the evolving evidence base, and monitor patients throughout the treatment course.

Exosome Regulatory Status

No exosome product is FDA-approved for injection or for the treatment, cure, prevention, or diagnosis of any disease. The FDA has issued public safety notifications regarding unapproved exosome products marketed with unsupported regenerative claims, and has pursued enforcement against clinics making therapeutic representations.[3] Exojuv sits in a different place. It is a plant-derived topical cosmetic preparation formulated from Centella asiatica for professional post-procedure application. It is not an injectable, and it is not an approved medical treatment. That distinction is what keeps both the product and the practitioner on the correct side of the line. Current evidence supports exosomes as cosmetic adjuncts, not as established therapeutic solutions. Practitioners should describe them accordingly in patient education, marketing materials, and informed consent, and should avoid any wording that implies treatment of a medical condition or FDA approval. Remaining within cosmetic claims and complying with local regulatory requirements is the practical safeguard here.

FAQs

Are exosomes FDA approved?

No. The FDA has not approved any exosome product for injection or therapeutic medical use, and has issued public warnings about unapproved products marketed for regenerative purposes. Exojuv is a plant-derived topical cosmetic preparation for professional use after aesthetic procedures.[3]

What is the difference between exosomes and PRP?

PRP is prepared from the patient's own blood and requires venipuncture and centrifugation, while exosomes are commercially prepared and applied topically with no blood handling. PRP has a longer clinical track record and a clearer regulatory position.

Are Exojuv exosomes plant-derived or human-derived?

Plant-derived. Exojuv contains approximately 5 billion exosomes obtained from Centella asiatica callus cultures, which distinguishes it from human-derived extracellular vesicle products.

Can exosomes be used alone?

Topical application without a preceding procedure is possible, but the open microchannels created by microneedling, RF microneedling, or laser resurfacing are central to how the protocol is intended to work.

How soon are results visible?

Reported changes in hydration and skin quality tend to emerge over several weeks and across a series of treatments. The evidence base is early-stage, and outcomes should not be presented to patients as guaranteed.

How should exosomes be stored?

Refrigerated at 2°C to 8°C, protected from light, and used promptly once reconstituted.

Where can licensed professionals buy exosomes?

Licensed healthcare professionals can buy exosomes online from Med Supply Solutions at wholesale pricing, with cold-chain shipping maintained through delivery.

Citations

[1] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau6977. https://pubmed.ncbi.nlm.nih.gov/32029601/ [2] Zhang B, Gong J, He L, et al. Exosomes based advancements for application in medical aesthetics. Front Bioeng Biotechnol. 2022;10:1083640. Published 2022 Dec 20. doi:10.3389/fbioe.2022.1083640. https://pubmed.ncbi.nlm.nih.gov/36605254/ [3] Center for Biologics Evaluation and Research. Public safety notification on exosome products. U.S. Food and Drug Administration. Published December 6, 2019. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products For licensed healthcare professionals only. The content of this page is provided for informational purposes and does not constitute medical advice. Exosome products are supplied for professional topical use only. They are not FDA-approved for injection or for the diagnosis, treatment, cure, or prevention of any disease.